Our results | average HbA1c levels | International comparison Diabeter
Our results
Lower than average HbA1c levels
HBA1c blood test helps monitor the glucose control of diabetic children and young adults. We provide our patients with good care and guidance and it shows in their HbA1c levels that are lower on average when compared to international data. This minimizes the complications caused by chronically elevated glucose levels.
The average glucose measurement over a period of two to three months can be measured in the blood via the so-called HbA1c levels. The national set value for children and young adults is lower than 7,5% (58 mmol/mol). For adults this is lower than 7%. The better you succeed to keep your HbA1c level below the target of 7,% the better your succeed to diminish the risk of developing complications as a result of type 1 diabetes.
In 2014, 48% of our patients with MDI reached an average HbA1c level of less than 7,5%. 58% of the patients who used an insulin pump gained an average HbA1c level of less than 7,5%. Patients who used both a pump and a sensor gained even better results. Of them 87% reached an average HbA1c level lower than 7,5% and 50% of this patient group even managed an average HbA1c level of less than 7%.
The results Diabetes reaches compared to international data (no Dutch national data are available) are good. But it is not only our HbA1c levels that are lower on average. The same goes for the percentage of our patients that needs to be submitted to hospital care for acute diabetes related problems. With an average of just 3% diabetes related hospital submissions per year in relation to a national average of 20% we clearly make the difference.
| Description | number at 31-12-2014 |
|---|---|
| Total of patients | 1543 |
| Diagnosed (primary) at Diabeter | 27% |
| Secondary referral to Diabeter | 73% |
| Type 1 diabetes | 1438 |
| Type 2 diabetes | 8 |
| Monogenetic diabetes (MODY) | 45 |
| Cystic fibrosis related diabetes (CFRD)Patients with pen therapy (MDI) | 42 |
| Patients with pen therapy (MDI) | 634 |
| Patients with insulin pump (CSII) | 876 |
| Pump treatment supported by glucose sensor (SAP) | 127 |
| Patients with HbA1c below 58 mmol/ml (7,5%) | |
| * 0 - 6 years | 58% |
| * 6 - 12 years | 69% |
| * 12 - 18 years | 46% |
| * Older than 18 year | 57% |
| Patients with HbA1c over 86 mmol/mol (10%) | |
| * 0 - 6 years | 0% |
| * 6 - 12 years | 1% |
| * 12 - 18 years | 6% |
| * Older than 18 years | 5% |
| Admission to hospital | average: 3% |
| * 0 - 6 years | 0% |
| * 6 - 12 years | 3% |
| * 12 - 18 years | 5% |
| * older than 18 years | 1% |
International comparison
